The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate CancerGoutam Chakraborty, Philip W. Kantoff, Konrad H. Stopsack et al.|Clinical Cancer Research|2022Cited by 51
Increased <scp> <i>MYBL2</i> </scp> expression in aggressive hormone‐sensitive prostate cancerYuki Yoshikawa, Christopher J. Sweeney, Konrad H. Stopsack et al.|Molecular Oncology|2022Cited by 17